Nerandomilast slowed lung function decline in people with IPF and PPF after a year of treatment, according to data from two ...

Yunu, the creator and leader in cloud-native imaging workflows for clinical trials, today announced a major new software ...

A new pre-surgery treatment strategy for inherited breast cancer has achieved an astonishing 100% survival rate, thanks to a ...

Social proof—seeing peers safely participate—reduces fear and builds trust in clinical trials. Sharing real stories and ...

Acne vaccine which is currently in Phase I/II trials, targets acne bacteria using mRNA technology and may revolutionize ...

Non-alcoholic steatohepatitis (NASH), a severe form of fatty liver disease, is projected to become the leading cause of liver ...

A local cancer treatment center is giving patients across West Texas renewed hope by highlighting the life-saving potential ...

The liposarcoma pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage liposarcoma drugs, inactive and dormant assets, a comprehensive ...

Detailed price information for Olema Pharmaceuticals Inc (OLMA-Q) from The Globe and Mail including charting and trades.

A blood test could soon help diagnose dementia. A new trial is underway in Dorset to explore the potential of blood tests to improve diagnosis rates. The study is taking place at Dorset HealthCare ...